AnalystsMike KratkyMike Kratky's Stock Forecasts
AnalystsMike Kratky
Sectors:
Industries:
Analyst Ranking
Top 27%
#1173 out of 4337 analysts
Average Return
+14.79%
Win Rate
50%4 out of 8
Risk vs Reward
Poor
Good
Mike Kratky's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Morphic Holding IncMORF | +109.25% | $26.27 | $54.97 | 2022-07-19 - 2023-07-19 | Buy |
Immunovant IncIMVT | +68.30% | $12.05 | $20.28 | 2022-11-03 - 2023-09-25 | Buy |
Galecto IncGLTO | +54.36% | $1.72 | $2.66 | 2022-08-02 - 2023-08-02 | Buy |
Rapt Therapeutics IncRAPT | +1.23% | $24.36 | $24.66 | 2022-08-10 - 2023-08-10 | Buy |
Mike Kratky Analyst Color
Get additional color on Mike Kratky's coverage of popular stocks
Mike Kratky's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Galecto IncGLTO | 2 | Hold | $2.00 | +250.26% | Downgrades | a month ago |
Pliant Therapeutics IncPLRX | 2 | Buy | $45.00 | +208.64% | Maintains | 8 months ago |
Madrigal Pharmaceuticals IncMDGL | 1 | Buy | $315.00 | +108.69% | Maintains | 9 months ago |
Axcella Health IncAXLA | 1 | Hold | $50.00 | +468.18% | Downgrades | 9 months ago |
Kymera Therapeutics IncKYMR | 2 | Hold | $31.00 | +103.28% | Maintains | 9 months ago |
Immunovant IncIMVT | 1 | Buy | $14.00 | -30.97% | Maintains | a year ago |
Viridian Therapeutics IncVRDN | 1 | Buy | $40.00 | N/A | Maintains | a year ago |
Rapt Therapeutics IncRAPT | 1 | Buy | $48.00 | N/A | Maintains | a year ago |
Morphic Holding IncMORF | 1 | Buy | $45.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.